Literature DB >> 16968493

Increased cardiovascular risk profile and mortality in kidney allograft recipients with post-transplant diabetes mellitus in Spain.

José Manuel González-Posada1, Domingo Hernández, Beatriz Bayés Genís, Lourdes Perez Tamajón, Javier García Pérez, Benito Maceira, Manuel Rivero Sánchez, Daniel Serón.   

Abstract

BACKGROUND: Post-transplant diabetes mellitus (PTDM) is associated with poorer outcomes in kidney transplantation (KT) but little information exists about the evolution of traditional cardiovascular risk (CVR) factors under this disorder.
METHODS: We retrospectively analysed CVR factors at 3, 12 and 24 months of follow-up and mortality at three yr in 3365 KT performed in Spain during the years 1990, 1994 and 1998 with a functioning graft after the first year. Three groups were considered: (i) (PTDM, n, 251), (ii) diabetes mellitus as primary disease (DM, n = 156) and (iii) the remaining patients (controls, n = 2958).
RESULTS: Recipient age, weight and body mass index (BMI) were higher in PTDM than in the other groups (p < 0.0001), with a lower increase of body weight during follow-up (p < 0.003). PTDM patients showed higher total-cholesterol levels than controls at one (p < 0.01) and two yr (p < 0.0009), and higher triglyceride levels than the other groups during follow-up (p < 0.002). Compared with Controls, PTDM patients had significantly higher systolic blood pressure at one (p < 0.001) and two yr (p < 0.005). Diastolic blood pressure was higher in PTDM and controls (p < 0.001), while pulse pressure was higher in PTDM and DM patients (p < 0.0001) during follow-up. Using Cox proportional hazards analysis, PTDM correlated with total mortality (RR = 1.55; range 1.05-2.3; p < 0.02) but not with cardiovascular mortality.
CONCLUSIONS: In Spanish KT recipients with graft function after one yr, PTDM is associated with a worse traditional CVR profile and a higher overall mortality. Although short-term cardiovascular mortality remains similar, better control of CVR factors is mandatory to prevent long-term cardiovascular mortality inherent to this population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16968493     DOI: 10.1111/j.1399-0012.2006.00532.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  3 in total

Review 1.  Body mass index and mortality in kidney transplant recipients: a systematic review and meta-analysis.

Authors:  Seyed-Foad Ahmadi; Golara Zahmatkesh; Elani Streja; Miklos Z Molnar; Connie M Rhee; Csaba P Kovesdy; Daniel L Gillen; Shah Steiner; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2014-10-21       Impact factor: 3.754

Review 2.  Obesity Paradox in Advanced Kidney Disease: From Bedside to the Bench.

Authors:  Neda Naderi; Carola-Ellen Kleine; Christina Park; Jui-Ting Hsiung; Melissa Soohoo; Ekamol Tantisattamo; Elani Streja; Kamyar Kalantar-Zadeh; Hamid Moradi
Journal:  Prog Cardiovasc Dis       Date:  2018-07-04       Impact factor: 8.194

3.  Validation of Identified Susceptible Gene Variants for New-Onset Diabetes in Renal Transplant Recipients.

Authors:  Hyeon Seok Hwang; Kyung-Won Hong; Jin Sug Kim; Yang Gyun Kim; Ju Young Moon; Kyung Hwan Jeong; Sang Ho Lee
Journal:  J Clin Med       Date:  2019-10-16       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.